Details for New Drug Application (NDA): 021738
✉ Email this page to a colleague
The generic ingredient in EXTINA is ketoconazole. There are fifteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ketoconazole profile page.
Summary for 021738
Tradename: | EXTINA |
Applicant: | Norvium Bioscience |
Ingredient: | ketoconazole |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021738
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, FOAM;TOPICAL | Strength | 2% | ||||
Approval Date: | Jun 12, 2007 | TE: | RLD: | Yes |
Expired US Patents for NDA 021738
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Norvium Bioscience | EXTINA | ketoconazole | AEROSOL, FOAM;TOPICAL | 021738-001 | Jun 12, 2007 | 7,553,835 | ⤷ Subscribe |
Norvium Bioscience | EXTINA | ketoconazole | AEROSOL, FOAM;TOPICAL | 021738-001 | Jun 12, 2007 | 8,026,238 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription